Liposarcoma
(Redirected from Atypical lipomatous tumor)
Liposarcoma is a tumor that arises from fat tissue. This tumor often occurs in the thigh, legs, behind the knee, or in the abdomen, but it can be found in other parts of the body, in the retroperitoneum; and, less often, in the head and neck area. Their primary occurrence in the skin is rare. Because a liposarcoma may grow into surrounding tissues or organs, it is considered a malignant tumor.
Subtypes[edit | edit source]
The World Health Organization classification of soft tissue tumors recognizes 5 types of liposarcomas: Well differentiated, which includes the adipocytic, sclerosing, and inflammatory subtypes; dedifferentiated; myxoid; round cell; and pleomorphic.
Cause[edit | edit source]
Doctors are not sure what causes liposarcoma. Mutations (changes) in genes found in fat cells may cause cells to grow uncontrollably, causing a tumor. Doctors have also found links between liposarcoma and other factors. Prior exposure to radiation or certain chemicals such as vinyl chloride (a toxic chemical used in making plastic) may cause liposarcoma in some people. In other cases, liposarcoma occurs due to hereditary conditions that are passed down among family members.
Symptoms[edit | edit source]
Some people with liposarcoma have no symptoms other than being able to feel a painless lump. People often notice these lumps after an injury, but trauma is not known to be a direct causative effect. You may notice symptoms as a lipomatous tumor grows and presses on surrounding nerves, muscles, or organs. Signs and symptoms of liposarcoma vary depending on the tumor’s location. They can include:
- Constipation
- Fatigue (extreme tiredness)
- Pain
- Trouble breathing
- Unexplained swelling
- Weakness
Additional images[edit | edit source]
Micrograph of a myxoid liposarcoma, H&E stain
Micrograph of a dedifferentiated liposarcoma, H&E stain
Diagnosis[edit | edit source]
The diagnosis is established by histologic examination of the tissue, i.e., biopsy or excision. Lipoblasts are often present; these are cells with an abundant clear multivacuolated cytoplasm and an eccentric darkly staining nucleus that is indented by the vacuoles.
Medical imaging[edit | edit source]
Ultrasonography may not be able to distinguish a liposarcoma from a benign lipoma, and therefore, MRI is the initial imaging of choice.
Treatment[edit | edit source]
The treatment for liposarcoma depends on the type, size, and location of the tumor. Surgery to remove the tumor is often the first treatment. When the tumor is in the abdomen, it may be difficult to remove completely, especially if the tumor is growing near important organs that cannot be removed.
If the entire tumor cannot be removed during surgery, radiation therapy may be used after surgery to kill any cancer cells that remain to reduce the chance of the tumor coming back (a recurrence).
Chemotherapy is another treatment that can kill remaining cancer cells following surgery, though it is not usually used to treat low-grade sarcomas. Sometimes radiation therapy or chemotherapy may be done prior to surgery to shrink the tumor; this may increase the chance of removing the whole tumor during surgery while limiting the impact to other organs. The medication(s) listed below have been approved by the Food and Drug Administration (FDA) as orphan products for treatment of this condition.
- Eribulin mesylate (Brand name: Halaven)Treatment of patients with unresectable or metastatic liposarcoma who have received a prior anthracyclne-containing regimen.
- Trabectedin (Brand name: Yondelis) For the treatment of patients with unresectable or metastatic liposarcoma or leiomyosarcoma who received a prior anthracycline-containing regimen.
Prognosis[edit | edit source]
The prognosis varies depending on the site of origin, the type of cancer cell, tumor size, depth, and proximity to lymph nodes.
Five-year survival rates vary from 56 to 100% based on histological subtype.
Epidemiology[edit | edit source]
Most frequent in middle-aged and older adults (age 40 and above), liposarcomas are the second-most common of all soft-tissue sarcomas, following malignant fibrous histiocytomas. Annually, 2.5 cases occur per million population.
Liposarcoma Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Deepika vegiraju